Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue by Offering Type

The following table presents the Company’s disaggregated revenue by offering type (in thousands):

	Three Months Ended September 30,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	685	1.9	%	$	570	1.8	%
Third-Party Payer products	3,917		11.1	%	3,425		10.7	%
Patient Services revenue recognized over time:
Direct rental services	1,923		5.4	%	1,840		5.8	%
Third-Party Payer rental services	12,277		34.8	%	11,003		34.5	%
Total Patient Services accounted for under ASC 606	18,802		53.2	%	16,838		52.8	%
Device Solutions revenue recognized at a point in time:
Products	4,731		13.4	%	3,593		11.3	%
Services	2,575		7.3	%	2,573		8.1	%
Device Solutions revenue recognized over time:
Services	1,841		5.2	%	1,807		5.7	%
Total Device Solutions accounted for under ASC 606	9,147		25.9	%	7,973		25.0	%
Total Revenue Accounted for under ASC 606	27,949		79.1	%	24,811		77.8	%
Patient Services lease revenue	1,978		5.6	%	2,451		7.7	%
Device Solutions lease revenue	5,393		15.3	%	4,647		14.6	%
Total Revenue accounted for under ASC 842, Leases	7,371		20.9	%	7,098		22.2	%
Total Net Revenue	$	35,320	100.0	%	$	31,909	100.0	%

	Nine Months Ended September 30,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	2,030	2.0	%	$	1,727	1.8	%
Third-Party Payer products	11,182		11.1	%	10,198		10.8	%
Patient Services revenue recognized over time:
Direct rental services	5,724		5.7	%	5,574		5.9	%
Third-Party Payer rental services	35,144		34.8	%	32,913		35.0	%
Total Patient Services accounted for under ASC 606	54,080		53.5	%	50,412		53.6	%
Device Solutions revenue recognized at a point in time:
Products	12,886		12.8	%	11,199		11.9	%
Services	7,442		7.4	%	7,608		8.1	%
Device Solutions revenue recognized over time:
Services	5,850		5.8	%	4,079		4.3	%
Total Device Solutions accounted for under ASC 606	26,178		25.9	%	22,886		24.3	%
Total Revenue Accounted for under ASC 606	80,258		79.5	%	73,298		78.0	%
Patient Services Lease Revenue	5,537		5.5	%	6,970		7.4	%
Device Solutions Lease Revenue	15,218		15.1	%	13,746		14.6	%
Total Revenue accounted for under ASC 842, Leases	20,755		20.5	%	20,716		22.0	%
Total Net Revenue	$	101,013	100.0	%	$	94,014	100.0	%

Schedule of Accounts, Notes, Loans and Financing Receivable

(dollars in thousands)	As of September 30, 2024		As of December 31, 2023		$ Change
Accounts receivable, net	$	22,761	$	19,830	$	2,931
Contract assets	$	980	$	1,271	$	(291)